Literature DB >> 2417866

Different receptor affinities of the enantiomers of BAY K 8644, a dihydropyridine Ca channel activator.

P Bellemann, G Franckowiak.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2417866     DOI: 10.1016/0014-2999(85)90680-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


× No keyword cloud information.
  7 in total

1.  Inverse drug screens: a rapid and inexpensive method for implicating molecular targets.

Authors:  Dany S Adams; Michael Levin
Journal:  Genesis       Date:  2006-11       Impact factor: 2.487

2.  Multiple voltage-sensitive calcium channels are probably involved in endogenous GABA release from striatal neurones differentiated in primary culture.

Authors:  J P Pin; J Bockaert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-08       Impact factor: 3.000

3.  (+)-isradipine but not (-)-Bay-K-8644 exhibits voltage-dependent effects on cat adrenal catecholamine release.

Authors:  M G López; P Michelena; L Gandía; A G García
Journal:  Br J Pharmacol       Date:  1991-02       Impact factor: 8.739

4.  Acetylcholine triggers L-glutamate exocytosis via nicotinic receptors and inhibits melatonin synthesis in rat pinealocytes.

Authors:  H Yamada; A Ogura; S Koizumi; A Yamaguchi; Y Moriyama
Journal:  J Neurosci       Date:  1998-07-01       Impact factor: 6.167

5.  Relationship between beta-adrenoceptors and calcium channels in human ventricular myocardium.

Authors:  D R Ferry; A J Kaumann
Journal:  Br J Pharmacol       Date:  1987-03       Impact factor: 8.739

6.  Nonmodal gating of cardiac calcium channels as revealed by dihydropyridines.

Authors:  A E Lacerda; A M Brown
Journal:  J Gen Physiol       Date:  1989-06       Impact factor: 4.086

7.  The Impact and Mechanism of a Novel Allosteric AMPA Receptor Modulator LCX001 on Protection Against Respiratory Depression in Rodents.

Authors:  Wei Dai; Xiang Gao; Dian Xiao; Yu-Lei Li; Xin-Bo Zhou; Zheng Yong; Rui-Bin Su
Journal:  Front Pharmacol       Date:  2019-02-19       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.